Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: Liquid biopsies: the future of cancer early detection

Fig. 3

Patient cancer cost associated with the first 12 months averaged over 11 cancer types (bladder, breast, colorectal, esophagus, kidney, liver, lung, ovary, pancreas, prostate and stomach), data adapted from [22]. Survival rates, averaged from SEER 5 -Year Survival Rates 2012–2018 across 11 cancer types (bladder, female breast, colorectal, esophagus, kidney, liver and intrahepatic bile duct, lung and bronchus, ovary, pancreas, prostate and stomach) data from both sexes unless stated otherwise, calculated from [28]

Back to article page